Nephros/$NEPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nephros
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
Ticker
$NEPH
Sector
Primary listing
Employees
36
Headquarters
Website
Nephros Metrics
BasicAdvanced
$39m
50.62
$0.07
1.47
-
Price and volume
Market cap
$39m
Beta
1.47
52-week high
$6.42
52-week low
$2.28
Average daily volume
33k
Financial strength
Current ratio
4.549
Quick ratio
2.983
Long term debt to equity
5.289
Total debt to equity
9.046
Interest coverage (TTM)
677.00%
Profitability
EBITDA (TTM)
0.803
Gross margin (TTM)
59.95%
Net profit margin (TTM)
4.06%
Operating margin (TTM)
3.54%
Effective tax rate (TTM)
1.52%
Revenue per employee (TTM)
$530,000
Management effectiveness
Return on assets (TTM)
3.31%
Return on equity (TTM)
7.76%
Valuation
Price to earnings (TTM)
50.62
Price to revenue (TTM)
1.997
Price to book
3.64
Price to tangible book (TTM)
4.11
Price to free cash flow (TTM)
-109.761
Free cash flow yield (TTM)
-0.91%
Free cash flow per share (TTM)
-0.033
Growth
Revenue change (TTM)
23.25%
Earnings per share change (TTM)
-6.46%
3-year revenue growth (CAGR)
18.43%
10-year revenue growth (CAGR)
25.39%
3-year earnings per share growth (CAGR)
-49.81%
10-year earnings per share growth (CAGR)
-23.02%
Nephros News
AllArticlesVideos
�Nephros Schedules First Quarter 2026 Financial Results Conference Call
MCAP MediaWire·4 weeks ago
Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
MCAP MediaWire·1 month ago
�Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
MCAP MediaWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs